AbbVie acquires Celsius Therapeutics to enhance inflammatory disease treatment options

By on    Pharma Industry News  

AbbVie acquires Celsius Therapeutics to enhance inflammatory disease treatment options

In a significant move within the biotechnology industry, AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical company, has completed the acquisition of Celsius Therapeutics, Inc., a pioneer in the development of therapies for inflammatory diseases. This acquisition, valued at $250 million in cash, underscores AbbVie’s strategic commitment to expanding its immunology portfolio by incorporating Celsius’ promising […]

AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio

By on    Pharma Industry News  

AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio

AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has announced the completion of its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company, for a total consideration of $137.5 million. This strategic acquisition underscores AbbVie’s commitment to expanding its robust immunology portfolio. Acquisition Details and Future Prospects The acquisition deal, which was first […]